Literature DB >> 7362730

Hypnotics: rebound insomnia and residual sequelae.

A N Nicholson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7362730      PMCID： PMC1429884          DOI： 10.1111/j.1365-2125.1980.tb04829.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  25 in total

1.  A comparison of the effects of flurazepam 30 mg and triazolam 0.5 mg on the sleep of insomniacs.

Authors:  G W Vogel; K Barker; P Gibbons; A Thurmond
Journal:  Psychopharmacology (Berl)       Date:  1976-05-05       Impact factor: 4.530

2.  The effect of triazolam on the sleep of insomniacs.

Authors:  G Vogel; A Thurmond; P Gibbons; K Edwards; K B Sloan; K Sexton
Journal:  Psychopharmacologia       Date:  1975

3.  The effect of lorazepam on anxious insomniacs' sleep as recorded in the home environment.

Authors:  G Globus; E Phoebus; J Humphries; R Boyd; D Gaffney; S Gaffney
Journal:  J Clin Pharmacol       Date:  1974-04       Impact factor: 3.126

4.  Flunitrazepam (Ro 5-4200) and sleep cycle in normal subjects.

Authors:  J M Monti; H Altier
Journal:  Psychopharmacologia       Date:  1973-10-15

5.  Effects of placebo and flurazepam on sleep patterns in insomniac subjects.

Authors:  J Kales; A Kales; E O Bixler; E S Slye
Journal:  Clin Pharmacol Ther       Date:  1971 Jul-Aug       Impact factor: 6.875

6.  The residual effects of flurazepam.

Authors:  A J Bond; M H Lader
Journal:  Psychopharmacologia       Date:  1973-09-28

7.  Nitrazepam: lastingly effective but trouble on withdrawal.

Authors:  K Adam; L Adamson; V Brezinová; W M Hunter
Journal:  Br Med J       Date:  1976-06-26

8.  Comparison of the residual effects of two benzodiazepines (nitrazepam and flurazepam hydrochloride) and pentobarbitone sodium on human performance.

Authors:  R G Borland; A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1975-02       Impact factor: 4.335

9.  Anxiety and sleep after fosazepam.

Authors:  S Allen; I Oswald
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

10.  Hypnotic efficacy of triazolam: sleep laboratory evaluation of intermediate-term effectiveness.

Authors:  A Kales; J D Kales; E O Bixler; M B Scharf; E Russek
Journal:  J Clin Pharmacol       Date:  1976 Aug-Sep       Impact factor: 3.126
View more
  9 in total

1.  Dose determinants of rebound insomnia.

Authors:  T A Roehrs; F J Zorick; R M Wittig; T Roth
Journal:  Br J Clin Pharmacol       Date:  1986-08       Impact factor: 4.335

2.  The use of short- and long-acting hypnotics in clinical medicine.

Authors:  A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335

Review 3.  A practical guide to prescribing in nursing homes. Avoiding the pitfalls.

Authors:  M Seppälä; L Sourander
Journal:  Drugs Aging       Date:  1995-06       Impact factor: 3.923

4.  Sleep laboratory study of the effects of midazolam in insomniac patients.

Authors:  J M Monti; J Debellis; E Gratadoux; P Alterwain; H Altier; L D'Angelo
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 5.  Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia.

Authors:  G E Pakes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

Review 6.  Temazepam: a review of its pharmacological properties and therapeutic efficacy as an hypnotic.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-05       Impact factor: 9.546

7.  Evaluation of single-dose hypnotic treatment before elective operation.

Authors:  M R Keighley; M Gannon; J Warlow; C R Jenkins; R J Gammon
Journal:  Br Med J       Date:  1980-09-27

Review 8.  [Benzodiazepines: significance of kinetics for therapy].

Authors:  H R Ochs
Journal:  Klin Wochenschr       Date:  1983-03-01

Review 9.  Guidelines for the rational use of benzodiazepines. When and what to use.

Authors:  H Ashton
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.